Literature DB >> 8582781

The treatment of zinc deficiency is an immunotherapy.

J W Hadden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8582781     DOI： 10.1016/0192-0561(95)00062-7

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN： 0192-0561


× No keyword cloud information.
  4 in total

1.  Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.

Authors:  Neil L Berinstein; Gregory T Wolf; Paul H Naylor; Lorraine Baltzer; James E Egan; Harvey J Brandwein; Theresa L Whiteside; Lynn C Goldstein; Adel El-Naggar; Cecile Badoual; Wolf-Herve Fridman; J Michael White; John W Hadden
Journal:  Cancer Immunol Immunother       Date:  2011-11-06       Impact factor: 6.968

2.  A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma.

Authors:  Theresa L Whiteside; Lisa H Butterfield; Paul H Naylor; James E Egan; John W Hadden; Lorraine Baltzer; Gregory T Wolf; Neil L Berinstein
Journal:  Cancer Immunol Immunother       Date:  2011-11-23       Impact factor: 6.968

Review 3.  IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

Authors:  Gregory T Wolf; Jeffrey S Moyer; Michael J Kaplan; Jason G Newman; James E Egan; Neil L Berinstein; Theresa L Whiteside
Journal:  Onco Targets Ther       Date:  2018-06-28       Impact factor: 4.147

Review 4.  Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis.

Authors:  Jiang Zhao; Xingyou Dong; Xiaoyan Hu; Zhou Long; Liang Wang; Qian Liu; Bishao Sun; Qingqing Wang; Qingjian Wu; Longkun Li
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.